| mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
0.19 |
2e-05 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.2 |
0.0001 |
| mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
| mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0002 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0005 |
| mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
0.19 |
0.0006 |
| mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
0.14 |
0.0009 |
| mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |